Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $8.40 Consensus Price Target from Analysts
Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month target […]